Scope Forward

A Tech-Startup and a GI Giant Just Redefined Clinical ResearchWhat happens when the largest GI practice in the country partners with a digital-native startup?You get more than scale. You get a radical redesign of how clinical research works—where trials no longer live on the sidelines of care, but at its very center. On The Scope Forward Show, Dr. Jonathan Ng (Founder & CEO, Iterative Health) and Dr. Casey Chapman (CMO, GI Alliance) announced a first-of-its-kind alliance:→ 80 research sites across the globe→ A shared platform for trial execution at the point of care→ And a vision to restore agency to physicians while unlocking equitable access for patients“It's not about trial volume. It's about raising the standard of care through research.”– Dr. Jonathan Ng“If this was just about ROI, we wouldn't be here. This is about building the future—with physicians, for patients.”– Dr. Casey ChapmanThis isn't a financial partnership. It's a systemic intervention—two years in the making—that breaks through recruitment bottlenecks, removes operational friction, and makes GI a launchpad for drug innovation. I'm excited about this announcement because it signals a shift not just for the organizations involved but for GI at large.Top 10 Highlights:A Historic Alliance: The world's largest GI research network is here—80 sites and growing.Two Years in the Making: What started as “what if” became a deeply aligned mission.Research Where Care Happens: Clinical trials integrated into community-based care.Choosing a Startup: GI Alliance chose Iterative Health for their patient-first, flexible approach.Beyond Tech: Iterative learned that tools alone can't solve broken systems.Focus on IBD & Liver: Targeting the conditions that matter most to real-world GI patients.Success = Empowerment: The goal is a generation of research-empowered GIs.Advice for Startups: Lead with listening, not just tech.Why Scope Forward: A platform aligned with values of physician empowerment.It Was Always About People: Partnership success came from shared priorities—not profit motives. 

What happens when a data scientist with IBS meets a digital health operator scaling virtual GI care? You get more than an acquisition—you get a glimpse of where gastroenterology is headed.On this episode of The Scope Forward Show, Asaf Kraus (founder of Dieta Health) and Bill Snyder (founder & CEO of Cylinder Health) join me to announce Dieta's acquisition. But we didn't stop at the deal.We talked AI, clinical outcomes, and why digestive health—despite affecting millions—remains underrecognized in digital health. Cylinder has already served 100,000 patients. GI care represents a $136 billion market, mostly buried in fragmented smaller markets. That's starting to change.Asaf's journey—from Uber to founding Dieta—shows what happens when lived experience meets data science. Bill's work at Cylinder is proof that virtual GI care can scale with rigor and stay grounded in patient outcomes.This conversation isn't just about what just happened. It's about what's next—and who's willing to build it.*Key takeaways:01:41 - Acquisition announcement on The Scope Forward ShowAsaf explains that he deliberately chose Praveen's platform because of its broad reach and innovation-focused GI community. He cites last year's GI Mastermind Conclave as an example of how influential this community can be.03:23- Dieta Health's OriginsAsaf recounts how a personal bout with IBS during his time as a data scientist at Uber inspired him to apply data-driven personalization to GI care.05:17 - Dieta's AI Revolutionizes GI DiagnosticsDieta ran four clinical trials and served 25,000 patients, confirming the viability of AI-based stool classification. Asaf references the trials to highlight that the solution is clinically grounded, not just theoretical.06:53 - Cylinder's Perspective and Asaf's MotivationBill details how he has known Asaf for years and admired Dieta's dedication to personalizing care.10:52 - The Scale and Scope of CylinderCylinder has already served 100,000 members with GI conditions and is on a rapid growth trajectory.15:12 - Future of Gastroenterology and AIPraveen asks both guests to imagine GI care a decade from now in light of recent AI leaps.22:36 - Bill's Background & Founding CylinderBill traces his career from Humana (understanding the payer/provider landscape), then Virta Health (diabetes-focused) to eventually founding Cylinder in 2021.25:27 - Fundraising for CylinderBill clarifies how investors recognized GI's massive, often-hidden market potential—buried in scattered claims data—and were drawn to Cylinder's proven outcomes and cost-saving evidence, resulting in about $50 million in raised capital.29:01 - Advice for entrepreneurs to fundraise in GIBill urges entrepreneurs to reveal GI's large, underrecognized market, noting that scattered claims data masks its full cost.32:19 - Bill's Path to SuccessBill highlights two key enablers: first, educating the market on GI's huge needs and second, strengthening partnerships with payers, employers, and providers.35:14 - Cylinder Health's operational modelCylinder's two-pronged offering combines a core product (health coaches + dietitians) with a full-stack virtual clinic (gastroenterologists + lab/prescription services).38:41 - How Cylinder differs from competitorsCylinder commits to measurable outcomes, ROI, and patient satisfaction.44:33 - Embracing Potential DisruptionWhen asked about AI advancements possibly surpassing human capabilities—thereby disrupting Cylinder's model—Bill views it as an opportunity rather than a threat.*#digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai #theshift

Dr. Brennan Spiegel, a physician, researcher, and author at the forefront of digital therapeutics, is challenging everything we know about gastroenterology. From virtual reality (VR) reshaping IBS treatment to AI rewriting the role of physicians, he sees the gut not just as an organ—but as an entire unexplored universe.In this conversation, he unpacks what the gut-brain axis is, why GIs are falling behind in microbiome research, and how gravity itself could be influencing gut health in ways we've never considered. He also dives into AI—how it's extending human capabilities while simultaneously shrinking cognitive function, and what this means for the future of medicine.This isn't just another conversation about the future of GI. It's a wake-up call. Are we evolving with technology, or is technology evolving us? Let's find out.*Virtual reality (VR) is transforming GI care – VR has been shown to alter cortisol levels, body temperature, and even immune responses, offering a new frontier for pain management and IBS treatment. The gut-brain-microbiome axis is real – The vagus nerve plays a critical role in two-way communication between the brain, gut, and microbiome, influencing motility, mood, and immune function. Startups, not GIs, are leading microbiome research – Despite its massive potential in GI, microbiome innovation is being driven by startups rather than physicians, creating a disconnect between research and clinical practice. Your gut is a universe – The microbiome is vast and largely unexplored, with a complexity comparable to the cosmos or human consciousness. Understanding it could shape the future of medicine.The microbiome is central to total human health – With 90-95% of serotonin produced in the gut, the microbiome affects not just digestion but also mental health, immune function, and chronic disease. Gravity is shaping human health in ways we don't realize – In his new book Pull, Dr. Spiegel introduces biogravitational medicine, explaining how conditions from IBS to depression may be linked to our relationship with gravity. AI knows you better than you know yourself – AI is not just replacing tasks—it's reshaping human thought and behavior, raising concerns about our increasing reliance on digital intelligence. Human cognitive abilities are shrinking—just like our motor skills did with machines – Much like how automation reduced our physical activity, AI may cause us to lose skills like memory, navigation, and decision-making.AI is both extending and shrinking the role of GIs – AI will enhance diagnostics, automation, and decision-making, but it will also reduce the need for traditional expertise in many areas, shifting physicians' roles. To stay relevant in the AI age, embrace technology but master human skills – The future of medicine will favor empathetic, wise, and adaptable physicians. AI won't replace doctors, but doctors who use AI will replace those who don't.*#digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai #theshift

The Scope Forward Show is Back – Kicking Off with Dr. Michael DragutskyThe wait is over—The Scope Forward Show returns with Season 5, and we're starting with someone who has been at the center of GI's transformation: Dr. Michael Dragutsky, Chairman of One GI.A lot has changed since we last spoke. Private equity in GI has evolved. Consolidation is accelerating. AI is no longer a distant concept—it's happening now.Where does this leave private practice? What's next after the first, second, and third bites of private equity? And for those who feel like they're losing control of their practice, is there still a way forward?Beyond business, we get into the bigger picture:  •  AI, robotics, and liquid biopsy—where is GI really headed?  •  When fewer endoscopists are needed, what happens next?  •  Will endoscopists become operators of machines rather than decision-makers?  •  Is there still room for the independent practice model?A Bigger Question Beyond GIAt the end of our conversation, I brought up something deeper—how AI isn't just changing medicine, but also changing us. We already rely on technology for memory, navigation, and decision-making. What happens when we no longer need to diagnose, think critically, or even perceive reality as we once did?Dr. Dragutsky and I explore this question as it applies to GI, but it's a much bigger shift than just gastroenterology and healthcare.

Dive deep with Sam Holliday, CEO of Oshi Health, and Dr. Treta Purohit, Medical Director at Oshi Health, as they share groundbreaking insights into the virtual GI care model and its transformative impact on gastroenterology. This conversation is a goldmine for anyone passionate about the future of digital health and innovative patient care solutions. Highlights:▶ Addressing the Gastroenterologist Shortage: Sam Holliday and Dr. Treta Purohit discuss the critical shortage of gastroenterologists and how Oshi Health is addressing this gap. By 2025, the U.S. is expected to be short of 1,500 gastroenterologists, making the need for innovative solutions more urgent than ever.▶ Pioneering Multidisciplinary Virtual Care: Oshi Health's care model integrates dietary, cognitive, and medical interventions to provide comprehensive GI care. This approach has shown impressive results, including 98% patient satisfaction and significant cost savings.▶ Enhancing Local GI Practices: The partnership between Oshi Health and local gastroenterologists is highlighted, demonstrating how virtual care can support and enhance traditional practices. This collaboration ensures patients receive the best possible care, whether virtual or in-person. Sam Holliday emphasizes the importance of collaboration in improving patient care: "The seamless exchange between local gastroenterologists and Oshi Health not only strengthens partnerships but also expands the reach and scope of GI practices, ensuring every patient receives the care they need." #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future

Praveen Suthrum interviews Dr. Aja McCutchen, Co-Founder, OLVI Health Dive deep with Dr. Aja McCutchen, as she unveils her groundbreaking venture into women's gut health. This conversation is essential for anyone interested in the nexus of gastroenterology, women's health, and innovation. Highlights:▶ Addressing the Gap in Women's Gut Health: Dr. McCutchen discusses the severe lack of data and tailored healthcare solutions for women facing gastrointestinal issues, emphasizing the need for specialized care. She outlines how her 40,000 women patient years of experience led to the formation of OLVI Health, a startup focused on addressing these unmet needs.▶ The Foundation and Mission of OLVI Health: The co-founders' journey began at a regional conference, sparking a shared vision to tackle the unique challenges women face in gastroenterology. Dr. McCutchen, alongside Dr. Asma Khapra and Dr. Latha Alaparthi, aims to transform care through innovative, data-driven solutions, starting with their AI-driven technology platform.▶ The Role of Technology and Future Vision: Highlighting the innovative use of AI and data analytics, Dr. McCutchen describes how OLVI Health plans to integrate digital health tools to better understand and treat women's GI conditions. She expresses an optimistic future where OLVI not only improves women's health but also serves as a model for how technology can bridge gaps in healthcare. Dr. Aja McCutchen's call to action is clear: "Jump in the pool and start working on it." Her proactive approach in launching OLVI Health illustrates her commitment to not just understanding women's health challenges but actively solving them with cutting-edge technology and a deep understanding of her patients' needs. #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai #womenshealth #guthealth

Praveen Suthrum interviews Andrea Cherubini, SVP Science, AI and Data, Cosmo IMD Dive into the fascinating world of AI in healthcare with Andrea Cherubini. This episode is a must-listen for anyone captivated by the role of AI in healthcare and particularly within gastroenterology. Cherubini's insights offer a unique window into the future of medicine, where AI not only supports but enhances medical expertise. Highlights: ▶ The Genesis of GI Genius: Andrea Cherubini shares the inception story of Cosmo IMD's collaboration with Medtronic in developing GI Genius, emphasizing the 'perfect storm' of opportunities that led to this revolutionary AI tool in gastroenterology. This narrative underscores the synergy of medical imaging expertise, AI, and pharmaceutical studies in pioneering medical diagnostics. ▶ Human-AI Hybrid Teams in Healthcare: A key takeaway from the conversation is the concept of human-AI hybrid teams. Cherubini articulates how these collaborations enhance the accuracy and effectiveness of medical diagnoses, surpassing the capabilities of human or AI working in isolation. This insight is critical for understanding the future trajectory of AI in healthcare. ▶ Navigating the AI Landscape in Gastroenterology: The interview sheds light on the broader implications of AI in gastroenterology, from real-time AI applications in endoscopy rooms to broader healthcare quality improvements. Cherubini elaborates on the challenges and potential of AI, advocating for responsible and innovative integration of these technologies in healthcare settings. Andrea Cherubini's message resonates with a sense of urgency and vision: the healthcare industry is on the brink of a transformative era with AI. His emphasis on the importance of embracing AI as a tool to augment human skill in medical practice is a clarion call to healthcare professionals worldwide. This conversation is not just an exploration of AI's current state in healthcare but a glimpse into a future where AI and human expertise collectively redefine medical excellence. #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai

Praveen Suthrum interviews Torrey Smith, Co-Founder & CEO, endiatx Dive deep with Torrey Smith, as he shares his groundbreaking journey in the world of medical technology. A fascinating look into the innovative use of drone technology within the field of gastroenterology. Highlights: ▶ From Aerospace to medtech: Torrey Smith shares his journey from aerospace engineering to pioneering medical device technology. Inspired by his personal experiences and science fiction, Smith's transition into medtech was driven by a desire to push the boundaries of what's possible in healthcare. ▶ The Creation of Pillbot™: The story behind the development of Pillbot™ is as intriguing as a sci-fi movie. Smith discusses how this advanced prototype, resembling a tiny quadcopter, is designed to navigate the human stomach. This innovation represents a significant leap in GI tract examination and treatment. ▶ The Future of GI Robotics: Smith envisions the human stomach as the perfect starting point for deploying tiny robots in the human body. He explains how the stomach's unique environment makes it an ideal playground for these swimming drones, potentially revolutionizing diagnostics and treatment in gastroenterology. Torrey Smith's innovative approach in blending deep tech with medtech, particularly in the GI field, marks a significant step forward in the evolution of healthcare technology. His work with endiatx and the development of Pillbot™ could pave the way for new, minimally invasive methods for diagnosing and treating GI conditions.

Praveen Suthrum interviews Dr. Stephen Steinberg, Founder and Chief Medical Officer at EndoSound Dive deep with Dr. Stephen Steinberg, as he shares his groundbreaking journey in revolutionizing Endoscopic Ultrasound (EUS) technology. This episode is a treasure trove for anyone interested in the intersection of gastroenterology, medical technology, and innovation. Highlights: ▶ The Genesis of a Revolutionary Idea: Dr. Stephen Steinberg recounts the inception of his innovative concept, inspired by technology initially intended for battlefield triage. He explains how the idea of integrating an ultrasound probe on a finger led to the transformative thought of attaching it to an endoscope, paving the way for advancements in gastroenterology. ▶ The Journey of EndoSound: Dr. Steinberg delves into the story of EndoSound, highlighting its mission to make EUS accessible and affordable. He discusses the development of the Endosound Vision System (EVS), a novel technology that transforms existing flexible video gastroscopes into ultrasound endoscopes, thereby democratizing this crucial diagnostic tool. ▶ Impact and Future of Endoscopic Technology: With a career spanning over four decades, Dr. Steinberg shares his insights on the evolution of endoscopic techniques and their impact on patient care. He emphasizes the role of EndoSound in creating better healthcare outcomes by making advanced diagnostics available to a broader range of providers and patients. Join this enlightening conversation with Dr. Stephen Steinberg, as we explore his innovative contributions to gastroenterology and the future of medical devices in enhancing patient care. #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai

Praveen Suthrum interviews Dr. Sanket Chauhan, Founder & CEO at Surgical Automations Dive deep with Dr. Sanket Chauhan, as he shares his insights on the integration of robotics in healthcare, particularly in gastroenterology (GI). This interview is a fascinating exploration for anyone interested in the intersection of robotics, AI, and healthcare. Highlights: ▶ Robotics in Gastroenterology: Dr. Sanket Chauhan discusses the precision and efficiency of robotic movements in medical procedures, emphasizing the mathematical precision and consistency that robots bring to the team. He advocates for the inclusion of robots as integral team members in healthcare. ▶ The Journey to Robotics: Dr. Chauhan shares his background in robotics, starting from his fellowship in Florida and his training under Dr. V.I. Patel, a renowned figure in robotic surgery. His journey reflects a blend of mechanical engineering and medical expertise, leading to innovations in surgical robotics. ▶ The Birth of Surgical Automations: The inception of Surgical Automations is rooted in Dr. Chauhan's vision during the COVID-19 pandemic. He explains how the company's focus initially wasn't on gastroenterology but on respiratory systems due to the pandemic's demands. The company's core technology, an AI-based endoluminal navigation system, is versatile and applicable to various medical fields, including GI. Dr. Sanket Chauhan's perspective on the future of gastroenterology in the context of robotics is enlightening. He says, "Don't forget that a robot is part of the team as well," highlighting the growing importance of robotics in enhancing healthcare delivery.

Praveen Suthrum interviews Dr. Austin Lee Chiang, Chief Medical Officer at Medtronic Endoscopy Dive deep with Dr. Austin Lee Chiang, as he shares his journey and insights on the intersection of healthcare, social media, and technology. This interview is a must-watch for anyone interested in the evolving landscape of gastroenterology, digital health, and the power of social media in medicine. Highlights: ▶ Social Media Influence: Dr. Chiang has achieved an impressive 180,000,000 views on TikTok and has over 650,000 subscribers across various platforms, demonstrating his significant impact in the digital space. ▶ The White House Meeting: Dr. Chiang discusses his experience at the White House, highlighting the importance of trained health professionals in shaping healthcare policy and the role of social media in these discussions. ▶ The Future of GI and AI: He shares his thoughts on the future of gastroenterology, particularly the emerging role of AI platforms, and teases an exciting announcement from Medtronic in 2024. Dr. Austin Lee Chiang, with his unique blend of medical expertise and social media influence, brings a fresh and impactful perspective to the field of gastroenterology. His insights provide valuable lessons on the importance of embracing technology and social media to advance healthcare.

Praveen Suthrum interviews Saurabh Jejurikar, Co-founder and CEO at EndoVisionAI Dive deep with Saurabh Jejurikar, as he explores the intriguing intersection of autonomous technology and medical innovation in gastroenterology. This interview is a must-watch for anyone interested in the cutting-edge advancements in digital health and gastroenterology. Highlights: ▶ From Autonomous Cars to Endoscopes: Saurabh Jejurikar discusses the unique transition from self-driving technology to the development of autonomous endoscopes. This shift represents a significant leap in applying advanced technology to improve patient care in gastroenterology. ▶ The Genesis of EndoVisionAI: Saurabh shares the origin story of EndoVisionAI, sparked by a conversation about the challenges in gastroenterology. With his co-founder, who has a background in autonomous vehicles, and inspired by his father, a gastroenterologist, they embarked on this innovative journey. ▶ A New Approach to Gastroenterology: The interview delves into how EndoVisionAI is changing the landscape of gastroenterology. By interviewing hundreds of doctors, from seasoned professionals to trainees, the company aims to enhance the quality of care and address the challenges faced by junior doctors in the field. Saurabh Jejurikar's vision for EndoVisionAI is not just about aiding experienced doctors but also about improving the overall quality of gastroenterological procedures and training. This conversation is a fascinating look at how cross-disciplinary innovation can lead to groundbreaking developments in healthcare. #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai

Praveen Suthrum interviews Dr. Erica Barnell, Co-Founder & Chief Medical Officer, Geneoscopy Dr. Erica Barnell, discusses the vital role of non-invasive diagnostics in preventing disease. This insightful conversation is a must-watch for anyone interested in the future of gastroenterology, digital health, and precision oncology. Highlights: ▶ The Importance of Non-Invasive Diagnostics: Dr. Erica Barnell emphasizes the significant role of non-invasive diagnostics in early-stage disease detection and prevention, particularly in colorectal cancer. She advocates for the detection of precancerous conditions rather than late-stage cancers, highlighting the potential of these technologies in changing patient outcomes. ▶ Innovations in Geneoscopy: Dr. Barnell shares updates on Geneoscopy's advancements, including their development of a novel stool-based RNA technology. This technology, awaiting FDA pre-market approval, is recognized as a breakthrough in colorectal cancer screening, especially for individuals under 50. ▶ Collaboration and Research: With her background in bioinformatics and precision oncology, Dr. Barnell discusses her work in developing new products targeting autoimmune and inflammatory diseases. Her collaboration with leading universities and biopharmaceutical companies is pivotal in improving gastrointestinal disease diagnosis, monitoring, and treatment. Dr. Erica Barnell, a pioneer in medical science, brings her expertise to the forefront in this engaging interview, offering a glimpse into the innovative approaches reshaping the landscape of healthcare diagnostics. #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future

Praveen Suthrum interviews Dunston Almeida, Founder and CEO at triValence Dive deep with Dunston Almeida, as he explores the transformative power of data in gastroenterology (GI). In his compelling narrative, Dunston Almeida underscores the necessity of integrating technology in GI: "In an era where technology is reshaping every aspect of our lives, the GI sector cannot remain an exception. By embracing innovative solutions and data-driven approaches, we can significantly advance patient outcomes and streamline healthcare delivery."Highlights: ▶ Exploring the Rich Data Landscape in GI: Dunston emphasizes the critical role of data in gastroenterology. He provides insights into how GI practitioners can harness their existing data, even from conventional sources, to significantly enhance their operational efficiency and patient care. ▶ Pioneering Change in the ASC Industry: Dunston addresses the pressing inefficiencies within the ambulatory surgery center (ASC) industry, particularly in the GI sector. He details a technological solution that streamlines supply chain processes, makes payments efficient, and offers advanced market analytics. ▶ The Path of a Healthcare Tech Innovator: Dunston Almeida's 25-year journey in the health-tech is nothing short of remarkable. From his academic roots at Cornell University to his transformative roles in companies like Zelis and eviCore, Dunston has consistently pushed the boundaries of innovation. #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #data

Praveen Suthrum interviews David C. Whitcomb, MD, PhD, Co-founder & Chief Scientific Officer at Ariel Precision Medicine #gastroenterology #gi #thescopeforwardshow #nextservices #digitalhealth #future

Praveen Suthrum interviews Asaf Kraus Founder & CEO, Dieta Health Dive deep with Asaf Kraus, Founder & CEO of Dieta Health, as he explores the innovative application of Artificial Intelligence (AI) in gastroenterology, particularly in stool analysis. This conversation is a must-watch for those interested in the intersection of technology and healthcare, especially in digestive health. Highlights: ▶ AI in Stool Recognition for GI Care: Asaf Kraus discusses the groundbreaking work of Dieta Health in using AI for stool analysis. He explains how AI can outperform patients in predicting what a human gastroenterologist would diagnose, based on the analysis of stool images. ▶ Personal Journey to Innovation: Living with IBS himself, Asaf's personal health challenges led him to a profound realization about the lack of data-driven personalization in gastroenterology. This epiphany was the catalyst for founding Dieta Health, aiming to revolutionize digestive health care through data and AI. ▶ From Uber Engineer to GI Innovator: Asaf shares his transition from being a data scientist at Uber to applying his expertise in machine learning to gastroenterology. His unique approach to applying AI in healthcare demonstrates the vast potential of technology in transforming medical diagnosis and treatment. Asaf Kraus's journey is not just a professional endeavor but a personal mission to make gastroenterology smarter, more tailored, and ultimately more human. His work at Dieta Health is paving the way for a future where AI leads in providing personalized solutions for digestive health challenges. #thescopeforwardshow #digitalhealth #innovation #gastroenterology

Dive deep with Dr. Michael Byrne, CEO & Founder of Satisfai Health, as he discusses the transformative potential of Artificial Intelligence (AI) in Gastroenterology (GI). This conversation is a treasure trove for anyone keen on understanding the future of AI in medicine and its implications for the healthcare industry. Highlights: ▶ The Elephant in the Room - Reimbursements in AI: Dr. Michael Byrne addresses the pressing question of who will bear the cost of integrating AI into GI. He is confident that the healthcare system will recognize the utility and benefits of AI, emphasizing that we are only at the beginning of witnessing its vast advantages. ▶ Journey of Satisfai Health: Dr. Byrne provides an update on the growth and achievements of Satisfai Health over the past year. From acquiring Docbot to building a suite of solutions for clinical practice and trials, Satisfai Health has been busy creating AI-driven innovations for GI. ▶ AI's Role in Precision Endoscopy: Dr. Byrne sheds light on the company's mission to revolutionize endoscopy through AI. He touches upon the company's endeavors in the clinical space, particularly in relation to IBD, Crohn's, and colitis. Dr. Byrne believes, "The healthcare system in general will see the utility and the benefit of AI... the benefits of AI in medicine, in GI, in endoscopy are literally huge." #thescopeforwardshow #gastroenterology #digitalhealth #aiingi

Praveen Suthrum interviews Dr. Bara El Kurdi, Assistant Professor of Gastroenterology & Hepatology, Virginia Tech Carilion School of Medicine | Host, GI Startup Podcast #thescopeforwardshow #gastroenterology #digitalhealth

In a world where lines between technology and healthcare blur more each day, I recently had the privilege of conversing with Omer Dror, CEO of Lynx.MD. Our dialogue ventured into the transformative realm of AI, the untapped potential of data, and the inevitable digital shift in gastroenterology. Self-driving cars once seemed a distant dream but today it's more than a reality. Similarly, present advancements in AI and data analytics are reshaping healthcare in ways we're only beginning to grasp. Highlights: ▶ The AI Revolution: Beyond mere automation, AI stands poised to redefine patient care, from intricate endoscopy procedures to holistic medical record analyses. ▶ Data's Uncharted Territory: As we've seen in other industries, data is a treasure trove waiting to be harnessed. But how do we extract and refine this "new oil"? ▶ The Gastroenterologist's Role: Amidst this tech whirlwind, the GI clinician remains central -- provided GIs step up to lead. Delve into our conversation. It's not just a glimpse into the future; it's a roadmap to navigate what's to come. Data indeed is an emerging ancillary - tap into it. Here's the interview. #thescopeforwardshow #gastroenterology #data #digitalhealth

Dr. Russ Arjal, co-founder and chief medical officer of Telebelly Health, joins The Scope Forward show to discuss the future of gastroenterology and the role of technology in reshaping the field. With a focus on patient-centric care and the integration of AI, Dr. Arjal provides a comprehensive overview of the challenges and opportunities facing GI practitioners today.Watch this super insightful interview.

In this episode of the Scope Forward Show, Praveen Suthrum interviews Dr. Daniel Neumann President & CSO, Capital Digestive Care | CEO, Trillium Health. The Scope Forward Show podcast is onto Season 3. We recently hosted a powerhouse guest on The Scope Forward Show - Dr. Daniel Neumann, gastroenterologist and trailblazer in healthcare. As the President and Chief Strategy Officer for Capital Digestive Care and CEO of Trillium Health, Dr. Neumann is at the cutting edge of gastroenterology's future. His insights provide a crucial roadmap for healthcare professionals in this rapidly evolving field. Dr. Neumann was also part of the GI Mastermind 2021 cohort. So what does the future of gastroenterology look like according to Dr. Neumann? The procedural orientation remains, but the spotlight shifts towards therapeutics over diagnostics. His emphasis on digital transformation, collaboration, and innovation form the triumvirate guiding the future of gastroenterology. #thescopeforwardshow #gastroenterology #digitalhealth

At the end of the interview, Sam Jactel, GI patient turned CEO talks about Thomas Nagel the philosopher. In a paper from 1974, Nagel famously asked us to contemplate “What is it like to be a bat?” He suggested that you may be able to study the behavior of a bat but you can never really know what it's like to be one. Sam takes that analogy to his own GI condition. He was tired of looking for answers within the industry. He was tired of not being seen or heard. And he ended up figuring out a solution that worked for him. Then he thought why not help other patients like him. That prompted him to go from being the CEO of his own condition to becoming the founder and CEO of Ayble Health. This digital GI startup has raised $4.6 million from investors. Watch this incredible interview. It's a sign of the times. Expect more patients to become digital healthcare providers because the industry isn't stepping up enough.

In this episode, Praveen Suthrum interviews Tom Serena (CEO, American Gastroenterological Association), Matt Schwartz (CEO & Co-founder, Virgo) and Andrea Vossler (Co-founder & Managing Director, Varia Ventures). * Scope Forward has always been about finding the way forward for gastroenterology. Naturally I was excited that a leading GI society such as the American Gastroenterological Association (AGA) was scoping forward by launching a venture capital fund called the GI Opportunity Fund (in partnership with Varia Ventures). What was even more exciting is that AGA chose to invest in Virgo to launch the fund. I interviewed Virgo's cofounder Matt Schwartz earlier this year - we talked about the value of data in GI. In this interview, you'll learn from Tom Serena (CEO of AGA) on why (and how) AGA chose to go down the route of venture investing. How the market opportunity for GI is enormous. How to invest and participate in this fund? If you are an entrepreneur, how to land an investment. More importantly, you'll understand the central premise of this interview. As Andrea Vossler, Cofounder and Managing Director of Varia Ventures said, physicians are the epicenter of medical care. You are the ones who are innovating. It's time to step forward and make your ideas into a reality. If you listen closely, Matt has this one piece of advice for GI entrepreneurs. *

I asked Jonathan Ng, founder and CEO of Iterative Health (formerly known as Iterative Scopes, an AI in GI startup) why investors recently gave them $150 million in funding. We didn't exactly get to the answer but I can fathom a thesis. Iterative Health's investors include the founders of Flatiron: Nat Turner and Zach Weinberg. A digital health company that advances cancer research. Pharma company Roche acquired Flatiron for $1.9 billion in 2018. Other investors of Iterative Health include Johnson & Johnson and Eli Lilly amongst others. Further key team members from Flatiron have been joining Iterative. My reading of the play here is straightforward. It's possible that investors want to repeat their thesis of Flatiron for Iterative but in gastroenterology. Big Pharma is funding AI in healthcare to develop more targeted therapy for the drugs they develop. Therefore the central premise of Iterative's offerings today seem to be on better recruitment for clinical trials. Physicians get an ancillary. Pharma automates patient recruitment. I came away super impressed with Jon's unwavering vision for AI in GI: equitable healthcare. When I asked how Iterative is different from Medtronic or others who were also working AI in GI. He repeated his vision - he said the desire for equitable healthcare differentiated them. While on a medical mission in Cambodia, it occurred to him that not all doctors are made equal. And that means patients can't get fair access to healthcare. Computer vision and AI could change that. He took action. Jon moved to MIT to study MBA and build on this idea. In a very short period, he developed the foundation for Iterative that went onto pave the way for AI in GI. Here's Jon changing gastroenterology for good. It's reasonable to say that the future of GI hinges on the execution of his vision.

Gastroenterologist Dr. Michael Owens did a thought experiment during the pandemic period. He asked himself, what would I do with my time if I'm not doing as many colonoscopies? That question led him to leave his large GI group to start up a multi-specialty GI group that takes advantage of the trends shaping the future of GI. For example, trends such as value based care, the microbiome, AI, colonics, single-use devices, genomic tests, liquid biopsy and so on. As he implies, Mike literally implemented the central premise of the book Scope Forward to build future on his own terms. He stands as a great example for GI 2.0. We often limit our choices to what's prevalent in the market. Join a hospital. Join PE. Merge with a large independent group. Kudos to Mike and his partners at Pearl Health Partners for having the courage to go against the grain and take a different, innovative approach. He says in the interview: if not now then when?

Dr. Larry Kosinski needs no introduction. As a leader, he's known for innovating, for breaking away from the norm and be a guiding light for the industry. After a successful private practice career, he helped his group transition to a PE platform to work on SonarMD, a venture-funded company he founded. Now, he's onto a surprising new startup, a stool-smelling e-nose called Voconomics (patent filed). In this freewheeling interview, we chat about everything that GI doctors must pay attention to. The risks of running non-diversified "colonoscopy factories" (as he calls them). The shift to digital that would catch most of the industry by surprise. How doctors can find the time from their busy lives to innovate by mastering the basics. And finally his take on private equity. This is such an important interview. It could quite easily alter the trajectory of many GI careers. It's time to wake up to the vulnerability that private practice GI is in. Dr. Kosinski's message is quite clear. Listen closely.

Data is indeed the new oil. Consider the strangeness of the scenario. GI doctors are supplying the fuel everyday that's going to set the old norm on fire but don't realize it. Because they are too busy generating the data! The wrong approach to this scenario is to fear this shift to digital and block it. You really can't. It's multiplying exponentially. The right approach is to figure out how to play the game or prepare for this changing scenario. Educate yourself on the future of GI and go there before the industry gets there. Erik's company Centaur Labs helps AI medical companies cleanup and annotate the data that GI and other specialties generate. They do so by taking a crowdsourced approach. Thousands of medical students from around the world label polyps and other medical information via a gamified app. Centaur gives that labeled data back to Medical AI companies. Those companies in turn feed that data to the AI so that the AI learns the right approach to care. I kept asking Erik how much time we have before AI becomes mainstream in GI. He initially said, we are early in the cycle. It's still far out. I persisted. Finally, he said we are possibly 5 years away. As Erik refers to a quote on AI, it's not about the AI replacing doctors. But the future belongs to doctors who will understand the AI and replace those who don't. Don't miss this one. Your future self will thank you for it.

As I write this note, I'm beginning to wonder what GI care means anymore. Just a few years ago, we were so sure of the role of the gastroenterologist in clinical care. Today, a flurry of digital innovations are urging the clinician to rethink her/his role. Surgeon and scientist and CEO of Alimetry, Professor Greg O'Grady reaffirmed how exponential technologies could make current clinical skills relatively obsolete. Gastric Alimetry is a FDA approved device (below) that non-invasively senses motility of the stomach. Sensors capture activity of the stomach, relay it to an app, advanced algorithms spot patterns and generate a report for the clinician. It's fascinating technology that's been in the works at the University of Auckland, New Zealand for a decade. Interestingly, in my book Scope Forward, I briefly talked about researchers working on a wearable device to track electrical activity of the digestive system and how algorithms would flag abnormalities (Page 51). Today it's a commercial reality. The future is indeed coming at us faster than we think! Don't miss this one.

In this episode of The Scope Forward Show, Praveen Suthrum interviews Dr. Haytham Gareer, Chief Medical Officer, Geneoscopy (RNA stool testing company). In November 2021, a month after Dr. Haytham Gareer joined Geneoscopy as CMO, the company raised $105 million in funding. The company is developing an RNA analysis platform to detect colorectal cancer (to be launched in 2023). A clinical study showed that when compared against the gold-standard colonoscopy, the platform demonstrated better sensitivity data in detecting advanced adenomas and colorectal cancer than other non-invasive tests. Dr. Gareer says Geneoscopy is going to increasing the number of colonoscopies being performed. However, it's obvious to me that digital biology is disrupting not just GI but many other specialties that are diagnosing cancer. I couldn't hold my curiosity and asked quite directly. Should gastroenterologists be worried about them? Should Cologuard be worried? Should Medtronic with its AI-based polyp detection system be worried? Because when there's a test that's going to detect adenomas with a fair degree of accuracy, why bother with diagnostic procedures? Dr. Gareer had a different and interesting view. As readers of Scope Forward, you already know my take. With more data, digital biology innovations such as RNA and DNA tests combined with machine learning would get extremely sophisticated. It'll even be able to predict things that we just can't with traditional approaches. Dr. Haytham completely agreed.

In this episode of The Scope Forward Show, Praveen Suthrum interviews Sonia Grego (Duke Professor and Co-Founder at Coprata Inc). The Coprata toilet captures lots of data post flush, runs #AI algorithms on the data and provides the analysis to both patients and doctors. Watch this insightful interview to understand why smart toilets are essential for proactive (not reactive) GI care. Watch the interview- https://lnkd.in/dkY4qmpE #data #digitalhealth #gastroenterology #ibs #stool #ai #engineering #innovation #scopeforward

While COVID was on and people sought help through meditation apps, the business world of behavioral health made a big announcement. Headspace (an app started by a former Buddhist monk) merged with Ginger.io to create Headspace Health in a $3 billion merger. You read that right. It's only natural that behavioral health showed up in gastroenterology. Curious, I reached out to GI psychologists Dr. Megan Riehl from Michigan Medicine and Dr. Madison Simons from Cleveland Clinic. What were these large institutions up to in this space? Why were they hiring psychogastroenterologists? Was there patient demand for something like this? What role would cognitive behavior therapy play in digital health? This is an evolving space with high demand - especially for those GI conditions that don't have straightforward solutions. Mental health and its role in the making and management of GI conditions is a space to watch. The brain-gut axis has a definite role to play in GI's future. Watch this one.

In this episode of The Scope Forward Show, Praveen Suthrum interviews Matt Schwartz CEO & Co-founder of Virgo. Virgo has captured 400,000 endoscopy videos so far and that number is growing exponentially. Virgo has also partnered with pharmaceutical companies to recruit the right candidates for clinical trials which led to a fundraise of $8 million with FCA Venture Partners and a soon-to-be-announced strategic investor. Watch this insightful interview to understand why 'data is the new oil' and how Virgo will dramatically influence GI care in the coming years-https://www.youtube.com/watch?v=5XUvl7RDzsQ #data #gastroenterology #scopeforward #endoscopy #AI #clinicaltrials

In this episode of The Scope Forward Show, Praveen Suthrum interviews Fehmida Chipty, MD, COO of digital health startup Satya Health Sciences | NovoLiver. Watch Dr. Fehmida Chipty's fascinating narration unfold fundamental issues of #gastroenterology. Why did she quit GI? What are the problems that we don't talk about? Why don't physicians ask for help? What her concerns are with our healthcare system? Is doing #colonoscopy after colonoscopy really helping solve for cancer? Your future self will want you to watch this one.

In this episode of The Scope Forward Show, Praveen Suthrum interviews Abe M'Bodj, Vice President at Westcove Partners, a leading healthcare-focused investment bank. During an economic downturn, would PE investments increase or drop? About 10% of the entire gastroenterology industry is under some form of PE as of mid-2022. What effect would recession have on "second bites" (exits) of existing PE platforms? What impact would it have on valuations? What big announcements can we expect before the end of the year? Find out more in this exclusive interview.

We are back with the next season of The Scope Forward Show where you'll get to meet innovators and leaders who are reimagining the healthcare system. The next phase of GI depends on innovators such as Aonghus and FoodMarble. Why? Because the industry is shifting from under our feet. Four trends are influencing GI: exponential technologies, consolidation, big brothers (such as hospitals, insurances) and changes in patient behavior. FoodMarble, a tiny device that analyzes digestive disorders such as IBS and SIBO, comes squarely in the middle of these trends. After selling 30,000 devices, what do they know about patients with IBS that a private practice does not? How can this be a new revenue-generating ancillary opportunity? The story of its growth is also interesting. An engineer gets an idea after seeing his girlfriend suffer. Ideates and develops the device in Ireland and China. Raises $6 million and sells globally - more than 2/3rd in the US. It's indicative of how the next phase of innovation would happen. Aonghus says, with "more data", you can come up with a "better diagnosis". True. Welcome to the evolving world of data-driven GI.

Every so often an interview reminds me yet again that the future is coming at us faster -- much faster. I'm still wrapping my head around what gastroenterologist and AI researcher Dr. Sravanthi Parasa told me: there would be a "1,000 algorithms" in 3 years in GI. This is big implications for the business of gastroenterology. The AI will indeed operate and guide us like a self driving car. In such a world, how would your role evolve as the endoscopist? What would happen to all the PE valuations that are based on GI manual productivity? How would the workflow change when you combine liquid biopsy and AI? Would your practice prefer hiring an AI vs. an average endoscopist? What if the insurance mandates the use of AI? Welcome to GI 2.0. ** Watch more interviews: https://www.nextservices.com/interviews/ ** #gastroenterology #TheScopeForwardShow #nextservices​​ #scopeforward​​ #healthcare​​ #technology​​ #healthtech​​ #aiingi #artificialintelligence #digitalhealth

Praveen Suthrum interviews Sam Holliday, CEO of the digital health company, Oshi Health. Two weeks ago, Oshi Health raised $23 million from well-known investors. It reinforces the fact that the landscape of gastroenterology is shifting toward digitization. In this interview, Sam Holliday (CEO of Oshi Health) talks about their plans to scale across all 50 states by the end of 2022. They also plan to hire gastroenterologists and partner with GI practices. Learn about what's attracting investor interest in digitization of gastroenterology. ** Watch more interviews: https://www.nextservices.com/interviews/ ** #gastroenterology #TheScopeForwardShow #nextservices​​ #scopeforward​​ #healthcare​​ #technology​​ #healthtech​​ #leadership​ #digitalhealth #oshihealth #digitalhealth #digitalGI

In a data driven world, it'll become acutely obvious that our system is broken in terms of racial disparity. The drugs we have don't work for all demographics. GI physician community is quite imbalanced in terms of race. Patients and future physicians will gravitate toward a more inclusive medical practice. It's already apparent that social determinants of health (SDH) influence health outcomes. Whether we recognize it or not, diversity and inclusion affects all of gastroenterology. It'll affect the future of GI. It'll affect private practice GI -- for sure. One of the most qualified people in our industry to understand this important topic is Dr. Aja McCutchen. She's a Board Member of United Digestive and Chair of Diversity, Equity and Inclusion at Digestive Health Physicians Association (DHPA). In this interview, she shares her story - from the suburbs of Cleveland ("crazy Dave" drew her to medicine) to leading the field (GI has only 1% African American women). You'll clearly understand the importance of paying attention to diversity and inclusion. #gastroenterology #TheScopeForwardShow #nextservices​​ #scopeforward​​ #healthcare​​ #technology​​ #healthtech​​ #leadership​ #digitalhealth #racism #DHPA #inequity

US Digestive Health is one the eight private equity backed GI platforms in the country. In this open-ended conversation, Dr. Mehul Lalani (VP, US Digestive), Gabriel Luft (Principal, Amulet Capital Partners), and Jerry Tillinger (CEO, US Digestive Health) talk about how the platform has evolved. It was interesting to learn that from the PE platform's perspective there's plenty of room to grow. We talked about whether PE in GI platforms would go public and how long they see the model to continue in GI. We went back and forth on a few points - especially on whether the company expects disruption from digital health. Don't miss this unique deep dive interview that brings together the GI physician, the CEO and the PE partner. #gastroenterology #TheScopeForwardShow #usdigestivehealth #USDH #nextservices​​ #scopeforward​​ #colonoscopy​​ #CRC​​ #screening​​ #privateequity​​ #healthcare​​ #technology​​ #healthtech​​ #leadership​ #digitalhealth

Elena Mustatea is the CEO and founder of Bold Health, a digital GI company that delivers digital therapeutics for the treatment of various GI conditions such as IBS. Their first app Zemedy is available in 190 countries. Now, they are hiring GIs and expanding in the US. In 2018, Forbes listed Elena in a 30 under 30 list. While private practice GIs are occupied with private equity, the world of digital health has been expanding. In Q1 2021, digital health attracted $9 billion in investments. In this first-of-its-kind interview, learn more about Bold Health and the world of digital therapeutics, CBT, integrative medicine and the advent of digital health in GI. Elena talks about their business and operational models. She delves into getting paid by insurances. Digital GI is a practical reality today. This train too is leaving the station. #gastroenterology #bolhealth #futureofhealthcare #scopeforward #TheScopeForwardShow

Praveen Suthrum, President of NextServices interviews Dr. Narayanachar Murali (South Carolina), Dr. Don Lazas (ObjectiveGI, Tennessee) and Dr. Chris Fourment (CRSG and Precision Research, Texas). Learn how to start clinical research as an ancillary. In this interview, you'll learn three different perspectives on clinical trials/research as an ancillary in a GI practice. We'll explore the pros/cons, costs, risks, and operating models. Consider this interview as a primer on starting up with clinical trials/research. In the coming weeks, we'll release more detailed interviews on the topic. **** Read the full transcript of this interview here - http://www.nextservices.com/how-to-start-clinical-trials-research-as-an-ancillary-in-gastroenterology/ **** SCOPE FORWARD - Releasing on 26th August, 2020. Visit our website now: http://scope-forward.com/ **** #clinicaltrials​ #ObjectiveGI​ #gastroenterology​ #CRSG​ #IBD​ #NASH​ #NAFLD​ #liverdiseases​ #hepatology​ #scopeforward​ #solopractice​ #risks​ #healthcare​ #medicine​ #ancillaries​ #pharmaceuticals​ #trials​ #research​

Dr. Scott Ketover is the President and CEO of MNGI Digestive Health (previously Minnesota Gastroenterology). MNGI is one of the country's largest independent GI practices. In a world of private equity, MNGI has firmly decided to stay independent. Dr. Ketover shares why they don't need to and what their growth strategy is. Our conversation explores many topics. Especially insightful are his views on how GIs must build programs for the entire GI tract and not just focus on endoscopies. He reflects on what he took away about the future during the pandemic. **** Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now - https://geni.us/scopeforward **** Please Like, Share and Subscribe to our channel to never miss out on such insightful interviews. #gastroenterology #TheScopeForwardShow #stayindependent #privateequity #consolidations #technology #digitalhealth #nextservices #scopeforward #colonoscopy #colorectalcancer #IBS #screening #technology #ancillaries #leadership

Dr. Brennan Spiegel is the author of VRx: How Virtual Therapeutics Will Revolutionize Medicine. He's the Director of Health Services Research, Cedars-Sinai Health System. This is a historic, one-of-a-kind interview. It lays out the digital future for GI from the lens of virtual reality (VR). Dr. Spiegel and his team have seen 3,000 patients via VR. The technology is no more new. FDA is approving solutions. Medicare is due to pay for VR. The challenge of private practice GI is to diversify from colonoscopy. Could VR be a new ancillary stream? Find out. Do not miss this one (35+ mins). **** #VirtualReality​ #gastroenterology​ #TheScopeForwardShow​ #VRx​ #AR​ #futureofhealthcare​ #medicine​ #healthcare

Praveen Suthrum, President at NextServices recently presented at the AGA Virtual Town Hall (that was held in collaboration with the DHPA). This is what you'll take away from this talk: 1) State of PE in gastroenterology 2) How exactly does PE operate and make money? 3) The PPM debacle of the 1990s 4) The four forces influencing GI consolidation 5) 8 considerations and 4 risks 6) How to stay relevant independent of your decision **** Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now - https://geni.us/scopeforward​

Rock Rockett is the Founder and Principal of Rockett Healthcare Strategies. Rock has been in the GI space for almost two decades now. As a business person, he saw GI physicians evolve. In this interview, we explore the big question on many people's minds: is it still possible to stay small and independent if you choose to? Do not miss this one (15+ mins). **** Read the entire transcript of the interview here - https://www.nextservices.com/interview-with-rock-rockett-yes-you-can-stay-small-and-independent-but-its-a-qualified-yes/ **** Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now - https://geni.us/scopeforward **** Please Like, Share and Subscribe to our channel to never miss out on such fascinating interviews. **** #gastroenterology​ #TheScopeForwardShow​ #stayindependent​ #​​staysmall​ #consolidations​ #technology​​ #nextservices​​​ #scopeforward​​​ #colonoscopy​​​ #colorectalcancer​​​ #CRC​​​ #screening​​​ #cancer​​​ #healthcare​​​ #technology​​​ #healthtech​​​ #leadership​​ #ASC

New Jersey-based Allied Digestive Health recently became the 8th private equity platform in gastroenterology. In this interview, Dr. Robert Gialanella, CEO/President and Dr. Nadeem Baig, Vice President of Allied Digestive Health talk about their journey – from being competitors to partners to choosing private equity and more. Learn about how they consolidated without private equity first, building the largest GI group in New Jersey. They talk about the “generational divide” between the senior and junior partners and reflected on how they tackled this situation at Allied. They also shared their views on consolidations, disruptions, and EBITDA assumptions. Finally, they laid out four trends as gastroenterology moves to the future. Watch this direct and lucid interview in full to understand the evolving landscape of GI. Read the entire transcript here - https://www.nextservices.com/interview-with-dr-bob-gialanella-and-dr-nadeem-baig-allied-digestive-health/

Praveen Suthrum, President at NextServices interviews Chris Metz and Steve Somers from Gastrologix, a GPO (Group Purchasing Organization). **** Read the entire transcript of the interview here - https://www.nextservices.com/interview-with-gastrologix-we-create-companies-that-physicians-can-have-ownership-in/ **** Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now - https://geni.us/scopeforward **** What if you could own companies you spend money on? What if you could save money on routine purchases by getting bulk rates? With those ideas, Christopher Metz and Stephen Somers founded Gastrologix, a Group Purchasing Organization (GPO). Gastrologix is the first GI-specific GPO that works with independent gastroenterologists. Today, they count 75 GI practices in their growing network. Watch this interview to understand on-the-ground insights from a GI-specific GPO. **** #gastroenterology #GPO #Gastrologix #nextservices #independentpractices #cost #savings #DHN #medicine #healthcare #scopeforward #ancillaries #infusion #vendorfunded

Praveen Suthrum, President at NextServices and Author, Scope Forward interviews Dr. Bergein Overholt. **** Dr. Bergein F. Overholt needs no introduction. He founded the Gastrointestinal Associates in Knoxville and led the group for four decades. He is also the past president of the American Society for Gastrointestinal Endoscopy and American Association of Ambulatory Surgery Centers. Dr. Overholt helped develop the flexible fibersigmoidoscope-colonscope, for which he earned many awards. In 1986, his efforts resulted in the establishment of the nation's first GI single specialty Ambulatory Surgery Center. Dr. Overholt has also taught many of today's GI practice leaders how to develop and manage their own GI-ASCs. In this one-of-a-kind interview, Dr. Overholt walks us through his four-decade-long journey, reflects on the new technologies, private equity, and shares his views on alignment among physicians. And finally, he shares timely and relevant advice for gastroenterologists. At a time when gastroenterology is at crossroads, Dr. Overholt says what needs to be said. Watch on. Don't miss the story of how the country's first GI ASC started. Read the transcript here - https://www.nextservices.com/interview-with-dr-gene-overholt-always-do-the-right-thing/ #gastroenterology #futureofhealthcare

Recently, Medtronic released a video showing how Pillcam (in partnership with Amazon) will enable home-based colonoscopy screening. Watch Giovanni Di Napoli, President of Medtronic GI sharing that vision. Naturally, I was curious to find out more and interviewed Giovanni few days ago. In this interview, he walks us through how Pillcam and GI Genius will evolve in the coming years. GI Genius is already approved in Europe and helps endoscopists use AI in detecting polyps. Further, he reflects on whether he sees Cologuard as competition or not and if insurances would mandate payment on adenoma detection rate (ADR). We also talked about how these developments will change the role of gastroenterologists. Do not miss this one (18+ mins) – get a glimpse into the near-future of GI. **** Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now - https://geni.us/scopeforward **** Read the transcript here - https://www.nextservices.com/interview-with-giovanni-di-napoli-medtronic-will-ai-replace-gastroenterologists/ **** Please Like, Share and Subscribe to our channel to never miss out on such fascinating interviews. **** #gastroenterology​ #medtronic​ #artificialintelligence​ #nextservices​ #scopeforward​ #GIgenius​ #PillCam​ #colonoscopy​ #colorectalcancer​ #CRC​ #screening​ #cancer​ #healthcare​ #technology​ #healthtech​ #precancer​ #lesions

Praveen Suthrum, President of NextServices interviews Dr. Ellen Scherl, Founding Director of the Jill Roberts Center for Inflammatory Bowel Disease. **** Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now - https://geni.us/scopeforward​ **** Dr. Ellen Scherl is the Research Director and Founding Director of the Jill Roberts Center for Inflammatory Bowel Disease (IBD), Weill Cornell Medicine. Dr. Scherl has recently been honored with the Rosenthal Humanitarian Award from the Crohn's and Colitis Foundation. Dr. Scherl is known nationally and internationally for her work in the field of IBD.

Praveen Suthrum, President, NextServices interviews Dr. Michael Weinstein, President & CEO of Capital Digestive Care and Past President, DHPA. Dr. Weinstein is also a member of the governing board at the AGA Institute. In the interview's second part, Dr. Weinstein talks about how many aspects of the medical practice can be done remotely. He reflects on the future of GI post COVID, his experiences with the giants of gastroenterology (e.g. Dr. Gene Overholt, the father of endoscopy) and what must fellows in GI must focus on. More importantly, he deeply contemplates on social disparity in gastroenterology. Watch Part 1: https://youtu.be/l5lmtKeqdIA Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now - https://geni.us/scopeforward